FOOD AND DRUG ADMINISTRATION ISSUES NOTICE: USE OF ORALLY INGESTIBLE UNAPPROVED PRESCRIPTION DRUG PRODUCTS CONTAINING FLUORIDE IN THE PEDIATRIC POPULATION; PUBLIC MEETING; ESTABLISHMENT OF A PUBLIC DOCKET; REQUEST FOR COMMENTS

WASHINGTON, June 16 -- Food and Drug Administration has issued a notice called: Use of Orally Ingestible Unapproved Prescription Drug Products Containing Fluoride in the Pediatric Population; Public Meeting; Establishment of a Public Docket; Request for Comments.

The notice was published in the Federal Register on June 16 by Grace R. Graham, Deputy Commissioner for Policy, Legislation, and International Affairs.

Summary: The Food and Drug Administration (FDA, the Agency, or we) is announcing the following public meeting entitled "Use of Orally Ingestible Unapproved Prescription Drug Products Containing Fluoride in the Pediatric Population." The purpose of the hybrid public meeting is to seek public input on the clinical use and safety con...